Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer
This study has been terminated.
(Study was terminated due to slow subject accrual)
Lyudmila Bazhenova, M.D.
Information provided by (Responsible Party):
Lyudmila Bazhenova, M.D., University of California, San Diego
First received: December 26, 2007
Last updated: July 12, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Estimated Study Completion Date:||July 2012|
|Primary Completion Date:||January 2012 (Final data collection date for primary outcome measure)|